NEWS
Dimerix fast-tracks kidney drug trial via new cash raise
MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship kidney drug… read more
Mesoblast gets boost from positive FDA news in USA
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after… read more
18 new senior healthcare executives sought for key roles
MELBOURNE: Eighteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
Analysts give Paragon-CH2 deal a thumbs up
MELBOURNE: Analysts at Bell Potter are backing the back door listing of the privately owned… read more
